Dr Jia Rong is a Researcher in the Department of Data Science & AI at the Faculty of Information Technology, Monash University, Australia. His work focuses on data mining, pattern recognition, and AI applications in bioinformatics, digital health, behavioral analysis, and social media analysis. Research Interests: Data Mining, Pattern Recognition, Complex Data Analysis, Bioinformatics, Digital Health, Behavioral Analysis, Social Media Analysis Current Role: Researcher, Department of Data Science & AI, Faculty of Information Technology, Monash University Dr Rong’s recent publications highlight the integration of deep learning and fuzzy cognitive maps in diverse domains. Key areas include pavement patch detection , traffic network prediction , medical imaging , educational technology , and debiased predictive analytics . His work also explores distributed stream computing , emotion recognition , and privacy-preserving algorithms , demonstrating a strong emphasis on both theoretical and applied data science across engineering, healthcare, and social sciences.
Susanne Krüger Kjær serves as Clinical Professor at the Department of Clinical Medicine, University of Copenhagen, under the Faculty of Health and Medical Sciences. She is based at the Department of Obstetrics and Gynaecology within Rigshospitalet (Copenhagen University Hospital), specifically affiliated with the Juliane Marie Centre and Gynaecological Clinic. Her work bridges clinical practice and population-based research using Denmark's comprehensive national health registries. Her research centers on cancer epidemiology with specialization in gynaecological malignancies, including ovarian, vulvar, penile, and thyroid cancers. Key interests encompass risk factor analysis of fertility treatments, hormonal contraception, HPV vaccination, and reproductive health impacts on cancer development. She employs large-scale cohort methodologies and Scandinavian registry data to investigate causal relationships and long-term outcomes. Recent 2025 publications reveal strong interdisciplinary trends across oncology, epidemiology, and digital pathology. Her work consistently addresses cancer prevention mechanisms through vaccination studies, algorithmic tumor assessment, and molecular epidemiology. The research demonstrates rigorous register-based methodology with international consortium collaborations, particularly in gynaecological cancer consortia. Professor Kjær maintains active clinical and research roles at Rigshospitalet's Gynaecological Clinic, contributing to both patient care and translational research. Her network includes extensive national collaborations within Danish healthcare institutions and international partnerships through multi-center studies like the Ovarian Cancer Association Consortium.
Christen Bertel L Andersen serves as Professor at the University of Copenhagen's Department of Public Health, specifically within the Section of General Practice. His work bridges clinical practice as a senior physician ( overlæge ) with academic research, holding both medical doctorate (dr.med.) and PhD qualifications. His primary research vehicle is the CopLab Research Group, which he chairs, utilizing the CopLab Database containing longitudinal paraclinical test results from primary care across Denmark's Capital Region. Andersen's research interests span epidemiology, myeloid diseases (particularly myeloproliferative neoplasms, eosinophilic syndromes, and chronic myeloid leukemia), laboratory medicine, and patient-reported quality-of-life outcomes. His work exemplifies translational research connecting laboratory findings, clinical practice, and population-level epidemiological data. Current investigations leverage the unique CopLab Database to explore disease etiology, progression, and health services research across multiple physiological systems. Recent publications demonstrate strong focus on population health analytics using large-scale clinical datasets, with notable work on lipid metabolism and mortality prediction, machine learning applications in diagnostics, maternal-fetal health outcomes, and hematological malignancy research. His team's interdisciplinary approach combines epidemiology, biostatistics, clinical medicine, and health policy analysis to generate evidence for clinical decision-making. The CopLab Research Group operates as a collaborative hub, actively seeking national and international partnerships for methodological innovation and disease-specific epidemiological studies. Their vision centers on advancing understanding of health trajectories through integration of paraclinical data with administrative registers, ultimately informing both clinical practice and health policy development in Denmark and beyond.
Pernille Holst is a Teaching Assistant Professor at the Department of Veterinary Clinical Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen. She works at the University Hospital for Companion Animals as both a veterinarian and oncology resident, specializing in cancer diseases in companion animals. Her academic appointment includes responsibilities in both the Section for Internal Medicine, Oncology and Clinical Pathology and the Section for Diagnostic Imaging & Companion Animal Surgery and Clinical Specialties. Dr. Holst graduated as a veterinarian from the University of Copenhagen in 2010 and has been employed at the University Hospital for Companion Animals since 2012. She is currently completing her training to become a European specialist in veterinary oncology (ECVIM-CA Oncology). Her research primarily focuses on cancer diseases, diagnosis, and treatment in dogs and cats. Key areas include osteosarcoma diagnosis, electrochemotherapy and calcium electroporation of tumors, and the use and effects of cannabinoids in companion animals. Her work bridges clinical practice with advanced diagnostic techniques, particularly in veterinary oncology. Analysis of her recent publications shows a strong focus on translational veterinary oncology, with particular emphasis on innovative cancer treatments and diagnostic approaches for companion animals. Her research spans from clinical studies on cannabis products to advanced imaging techniques like hyperpolarized MRI and PET for cancer metabolism assessment in canine patients. Through her teaching activities, Dr. Holst contributes to both bachelor and master's level veterinary education, supervising projects in clinical oncology and veterinary radiology. She teaches in the Medicine, Surgery, and Reproduction program for small companion animals with a focus on oncology for dogs and cats. Dr. Holst is actively involved in clinical research projects related to bone cancer and electrochemotherapy, collaborating with various research teams at the University of Copenhagen. Her work demonstrates a commitment to advancing veterinary cancer care through both clinical practice and scientific investigation.
Prof. Heinrich Leonhardt is a faculty member at the Ludwig Maximilian University of Munich (LMU Munich) in the Human Biology & BioImaging department. His research focuses on DNA methylation , epigenetic regulation , and live cell imaging technologies . Technologies Developed: Fluorescent nanobodies (chromobodies), tools for DNA methyltransferase activity measurement, high-throughput/super-resolution microscopy. Research Goals: Apply epigenetic programming to cellular differentiation , tissue regeneration , and cancer therapy . His work integrates genetic , biochemical , cellular , and biophysical approaches in vitro and in vivo using embryonic stem cells and transgenic animals . Recent publications highlight interdisciplinary studies in chromatin organization , RNA splicing , and antibody-drug conjugate development .
Amanda V. Bakian, PhD, is a Research Associate Professor in the Department of Psychiatry at the University of Utah, where she also holds an adjunct position in Family & Preventive Medicine. She serves as Director of the Utah Registry of Autism and Developmental Disabilities (URADD), overseeing public health surveillance for autism and developmental disabilities. Her research investigates environmental, geographical, and familial risk factors for psychiatric conditions including autism spectrum disorder and suicide, with emphasis on air pollution interactions and spatial epidemiology. Education: Postgraduate Fellowship, Kyoto University PhD, Utah State University MS, Utah State University BA, Colby College Dr. Bakian's research integrates environmental epidemiology, spatial statistics, and gene-environment interactions to identify population-level psychiatric risk patterns. She leads NIH-funded projects examining air pollution's impact on suicide risk and directs Utah's autism prevalence tracking. Her work emphasizes public health surveillance systems and geographical disparities in psychiatric outcomes. Recent publications (2024-2025) demonstrate strong focus on suicide risk factors, autism epidemiology, environmental health impacts, and mental health disparities. Methodologies include large-scale population studies, spatial analysis, genetic investigations, and public health surveillance innovations across diverse populations including youth, transgender individuals, and economically disadvantaged groups. Major Grants & Initiatives: Principal Investigator: NIH-funded study on air pollution/weather impacts on suicide risk Director: Utah Autism and Developmental Disabilities Monitoring Project Member: Utah Suicide Genetic Risk Study She leads the URADD surveillance team and collaborates extensively with national networks including the Autism and Developmental Disabilities Monitoring Network.
Maragatha Kuchibhatla is Professor of Biostatistics and Bioinformatics and Professor in Psychiatry and Behavioral Sciences at Duke University School of Medicine. She serves as Senior Fellow in the Center for the Study of Aging and Human Development and leads the Biostatistics, Epidemiology, and Research Design (BERD) Methods Core within the Division of Biostatistics. Her educational background includes a Ph.D. from Texas A&M University (1992). Ph.D., Biostatistics, Texas A&M University, 1992 Kuchibhatla's research specializes in advanced statistical methodologies for complex clinical data, with emphasis on longitudinal modeling (latent growth curve/class models), classification algorithms, and psychiatric clinical trial design. Her work bridges biostatistical innovation with practical applications in trauma recovery, geriatric care, and health disparities research, particularly in comorbid populations. Recent publications (2024-2025) demonstrate strong interdisciplinary focus across trauma surgery, hematology, global health, and emergency medicine. Key trends include development of predictive models for bleeding/thrombosis risks, age-neutral surgical protocols, and implementation of machine learning in resource-limited settings—showcasing her ability to translate statistical theory into life-saving clinical tools. She currently directs 9 major grants totaling over $20 million in active funding: POWER: Predicting Obesity with Enhanced EHR Resources (NICHD, 2022-2027) Machine learning for thyroid cytopathology in LMIC (NCI, 2021-2027) Personalized Targeted Nutrition via StructurEd Delivery (DoD, 2022-2026) Ultrasound-guided nerve block training (SAEM, 2025-2026) Bystander interventions in opioid cardiac arrests (EMF, 2025-2026) Lung transplantation CT-based selection (RSNA, 2025-2026) Trauma nutrition optimization (Fresenius Kabi, 2024-2026) Elderly trauma ventilation care (NIH, 2020-2025) Nasopharyngoscope cancer screening network (NIH, 2019-2025) Her grant portfolio reflects strategic focus on trauma recovery, health equity, and diagnostic innovation. Kuchibhatla collaborates extensively through Duke's BERD Core and the Center for the Study of Aging, contributing biostatistical leadership to multidisciplinary teams addressing critical gaps in trauma care, psychiatric treatment, and global health access.
Kornél Dános serves as an Assistant Professor at the Department of Otolaryngology, Semmelweis University, where he has been employed since September 2012. As a head and neck surgeon and otolaryngologist, he specializes in head and neck oncology and teaches medical and dental students in both Hungarian and English languages. His research centers on personalized therapy and surgical treatment of head and neck cancers, with particular emphasis on HPV-induced oropharyngeal cancers and thyroid surgery. He is a dedicated advocate for cancer prevention, implementing both primary and secondary prevention strategies through organized screening programs and educational initiatives developed in collaboration with the European Society of Head and Neck Oncology. Dr. Dános actively supervises TDK (Tudományos Diákköri) undergraduate research projects and PhD candidates. His clinical and academic work integrates surgical innovation with public health outreach via platforms like fejnyakidaganatok.hu and fejnyakibetegut.hu to improve patient outcomes in head and neck cancer care.
Jie Zheng is Professor of Ophthalmology at UCLA's David Geffen School of Medicine, where his research integrates chemical, computational, structural, and systems biology to develop therapeutics targeting visual system signaling pathways. His laboratory focuses on structure-based drug discovery and repositioning for ocular diseases. Dr. Zheng's work centers on Wnt signaling modulation and steroid responses in trabecular meshwork biology and limbal stem cell maintenance. His laboratory systematically investigates how small molecules and proteins can regulate signal transduction pathways implicated in glaucoma and corneal disorders, with emphasis on structural mechanisms driving therapeutic development. Analysis of his 2022-2025 publications reveals dominant themes: Wnt pathway manipulation (inhibitors/activators), trabecular meshwork responses to corticosteroids and pollutants, and extracellular vesicle therapies for ocular surface regeneration. His research consistently bridges structural insights with therapeutic applications for glaucoma and stem cell deficiency. Dr. Zheng leads a multidisciplinary research team at UCLA advancing ophthalmic drug discovery through structural biology and computational approaches. While specific advising activities and grant details are not provided in available materials, his laboratory maintains active investigation into disease mechanisms and therapeutic targeting.
Tae-Hwa Chun is an Associate Professor at the University of Michigan in the Department of Internal Medicine - Metabolism, Endocrinology, and Diabetes. He is affiliated with multiple centers including the Biointerfaces Institute, MExperts-Center for Global Health Equity, Global REACH, and Caswell Diabetes Institute. As a physician-scientist, his work bridges clinical endocrinology with mechanistic research in adipose tissue biology and ECM remodeling. OBESITY & DIABETES RESEARCH THYROID EYE DISEASE STUDIES 3D TISSUE ENGINEERING EXPERT NIH/NSF GRANT RECIPIENT His research focuses on extracellular matrix (ECM) dynamics in obesity, diabetes, and cardiovascular diseases, particularly exploring how adipose and skeletal muscle tissues remodel under metabolic stress. Key discoveries include the role of MT1-MMP in adipose expansion and TCF21-driven IL6 expression in visceral adipose stem cells. He employs cutting-edge technologies like 3D organoids and on-chip adipose models to study disease mechanisms ex vivo. Recent publications highlight thrombospondin-1's role in diaphragm dysfunction and HIF2A-LOX pathway involvement in thyroid-associated orbitopathy. His work has been supported by continuous NIH funding since 2005 and an NSF CAREER award in 2018. NIH R01 - Diaphragm Remodeling (2019-2024) NSF CAREER - Beta Cell Dysfunction (2018-2024) NIH R03 - Adipose Collagenolysis (2011-2013) AHA GRANT - MT1-MMP in Atherosclerosis (2008-2009) He co-mentors Ph.D. candidates at the Biointerfaces Institute and teaches M1 Disease Mechanism to clinical residents. His lab's technical innovations include immunomagnetic ASC separation and engineered ECM platforms for tumor cell expansion.
Michael J. May is an Associate Professor in the Department of Biomedical Sciences at the University of Pennsylvania School of Veterinary Medicine. His research bridges immunology, molecular biology, and vascular biology, focusing on the role of NF-κB signaling in disease contexts. Education: PhD in Vascular Biology Research from King’s College London (1996) Postdoctoral Training: Howard Hughes Medical Institute (1996-1998), Irvington Institute for Immunological Research (1998-2000) at Yale University Medical School May’s research explores NF-κB signal transduction pathways , emphasizing their role in chronic inflammation, cancer, and immune responses. His lab investigates how aberrant NF-κB activation drives disease progression, with key interests in: Regulation of the IκB Kinase complex Endothelial cell function in inflammation Development of cell-permeable peptide inhibitors Publications highlight his work on noncanonical NF-κB regulation , B cell signaling, CAR T cell survival, and translational applications in lymphoma treatment. His team combines genetic, molecular, and clinical approaches to dissect pathway dysregulation and design targeted therapies. May leads the May Laboratory at the Penn Vet Cancer Center, applying peptide transduction technology to modulate signaling in immune-mediated diseases and cancers.
Peter C. Whybrow, M.D. is the Judson Braun Distinguished Professor and Executive Chair of the Department of Psychiatry & Biobehavioral Sciences at the David Geffen School of Medicine, University of California, Los Angeles. Recruited to UCLA in 1997 from the University of Pennsylvania, Dr. Whybrow has established himself as a leading authority in psychiatric research and clinical practice with an extensive publication record spanning over three decades. Dr. Whybrow received his medical training in London and North Carolina, with specialization in endocrinology and psychiatry. His educational journey began in England where he was a member of the scientific staff of the British Medical Research Council before joining Dartmouth Medical School in the 1970s, where he served as Chairman of Psychiatry and later as Executive Dean. He was recruited to the University of Pennsylvania in 1984 as the Ruth Meltzer Professor and Chairman of Psychiatry until 1996. Dr. Whybrow is an internationally recognized authority on depression, manic-depressive disease, and the effects of thyroid hormone on brain and human behavior. His research spans multiple domains including bipolar disorder, mood disorders, digital mental health, and the application of artificial intelligence in psychiatry. Recent work focuses on the relationship between environmental factors like solar insolation and bipolar disorder, as well as the impact of digital technologies on mental healthcare delivery. He has pioneered the development of digital tools for mood disorder monitoring, notably the ChronoRecord software used in longitudinal bipolar disorder studies for over 20 years. Analysis of Dr. Whybrow's recent publications reveals a strong focus on the intersection of technology and mental health. His work examines artificial intelligence applications in psychiatry, digital mood tracking systems, and the impact of environmental factors on bipolar disorder. There's a clear trajectory toward understanding how digital tools can enhance mental healthcare while addressing associated ethical concerns and implementation challenges. His research consistently bridges neuroscience, endocrinology, and digital innovation to develop more effective assessment and treatment approaches for mood disorders. Dr. Whybrow has received numerous honors including: Fellow of the Royal College of Psychiatrists Fellow of the American Association for the Advancement of Science Fellow of the American College of Psychiatrists Fellow of the American Psychiatric Association Los Angeles Times best seller for "American Mania: When More Is Not Enough" Cited by the New York Times Magazine as one of 78 notable ideas for 2005 As Executive Chair of the Department of Psychiatry & Biobehavioral Sciences at UCLA, Dr. Whybrow oversees significant research initiatives and clinical programs. His leadership extends to developing digital tools for mood disorder monitoring, as evidenced by the ChronoRecord software used in longitudinal bipolar disorder studies for over 20 years. His research has been supported by various grants focusing on the relationship between environmental factors and mood disorders, thyroid hormone effects on brain function, and digital innovations in mental healthcare. He frequently advises universities, foundations, and government agencies on psychiatric matters. Dr. Whybrow leads research teams focused on understanding the biological underpinnings of mood disorders, with particular emphasis on how environmental factors like light exposure influence bipolar disorder. His work integrates neuroscience, endocrinology, and digital health technologies to develop more effective assessment and treatment approaches for mood disorders. He has authored five books including "A Mood Apart" and "American Mania: When More Is Not Enough," demonstrating his commitment to translating complex scientific concepts for broader public understanding.
Dr. Cassy Spiller is a Research Fellow at the School of Biomedical Sciences, The University of Queensland. She is a member of the Bowles group, focusing on developmental reproductive biology and germ cell research. Her work spans sex determination, meiosis regulation, and the intersection of toxicology with reproductive mechanisms. Education : Bachelor of Science (University of Newcastle), PhD (University of Queensland, 2009). Her research interests include: Developmental Biology: Mechanisms of germ cell fate and sex differentiation. Reproductive Biology: Regulation of meiosis in fetal gonads. Toxicology: Impact of environmental chemicals on reproductive development. Genetics: Role of signaling pathways (e.g., BMP, STRA8, NFIX) in germ cell development. Article Trends : Recent publications emphasize chemical toxicity, meiosis transitions, and biomarker discovery in testicular cancers, with collaborations across developmental biology, toxicology, and genetics. Scientific Awards : Society for Reproductive Biology Open Grant ARC Discovery Projects Cancer Council Queensland UQ Postdoctoral Fellowship Dr. Spiller is available for supervision and has advised PhD projects on germ cell meiosis, Cripto signaling, and NFIX function. She contributes to adverse outcome pathways in toxicology and is involved in ex vivo culture systems. Her work is supported by grants from national and international foundations.
Herbert Yu, MD, PhD, is an Adjunct Professor at Yale School of Public Health's Department of Chronic Disease Epidemiology. With over 20 years of cancer research experience, he specializes in molecular epidemiology focusing on gene-environment interactions and epigenetic regulation in cancer development. His research spans breast, ovarian, pancreatic, liver, and uterine cancers. Education: PhD, University of Toronto (1996) MSc, University of Toronto (1990) MD, Shanghai Medical University (1983) Research focuses on: Molecular characterization of insulin-like growth factors in breast/ovarian cancers DNA methylation in cancer risk stratification GWAS studies on endometrial cancer Development of non-invasive cancer biomarkers Publication analysis reveals predominant focus on: Cancer biomarker discovery (50%) AI/ML applications in oncology (20%) Molecular pathway analysis (20%) Epidemiological risk modeling (10%) Awards and Honors: Wang Fellowship for International Study of Public Health American Association for Clinical Chemistry Young Investigator Award Mitchell Scholarship in Cancer Research International Scholar Award in Breast Cancer Research Research leadership includes principal investigator roles on NIH-funded projects including a multimillion-dollar grant for liver cancer research. Collaborates extensively with Yale Cancer Center researchers on molecular oncology studies.
Susan Bonner-Weir is a Senior Investigator at Joslin Diabetes Center and a Professor of Medicine at Harvard Medical School . She holds the Diabetes Research and Wellness Chair and has dedicated over 35 years to studying the endocrine pancreas, focusing on β-cell dynamics in health and disease. Ph.D. in Biology, Case Western Reserve University Graduate, Rice University Her research spans three core areas: Islet architecture and its functional implications Regulation of β-cell mass and function Lifespan changes in β-cell phenotype She has pioneered work on adult pancreatic progenitor cells, β-cell senescence, and thyroid hormone-driven maturation, with implications for diabetes therapy. Recent work highlights her discovery of β-cell heterogeneity across life stages and the role of metabolic stress in accelerating aging. Her lab’s studies on the Joslin 50-Year Medalist cohort revealed persistent insulin-positive cells in type 1 diabetes, suggesting ongoing neogenesis countered by autoimmunity. Notable awards include: AAAS Fellow (2012) Helmholtz Diabetes Award (2021) Her contributions to peer-reviewed publications (over 210) and editorial boards across endocrinology and diabetes journals underscore her leadership in the field. Collaborative efforts with institutions like Beth Israel Deaconess Medical Center and Boston Children’s Hospital further amplify her impact.
